Search results for: 'main call pace'

The focus of this report is on clinical-grade remote patient monitoring (RPM). RPM is a digital solution that involves secure transmission of medical data collected on devices, via information and communication technologies, through text, sound, images or other forms needed for the prevention, diagnosis, treatment and follow-up of patients. Health ...

19 Jan 2018  |  North America  |  Market Research

The Global Immuno-oncology Therapeutics Market—Adoptive T-cell Therapies, Forecast to 2022

The Next Generation of Cancer Therapies

Infographics

×

Key Issues Addressed

Immuno-oncology refers to drugs that are used to stimulate the human immune system to target the fight against cancer. The immune system is capable of recognizing and eliminating foreign substances, including tumor cells. Tumors have, however, been able to escape detection by the immune system. There are drugs that can empower the immune system cel...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

23 Mar 2017  |  Asia Pacific  |  Market Research

APAC Molecular Diagnostics Market, Forecast to 2021

Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

Infographics

×

The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...

28 Jun 2021  |  North America  |  Market Outlook

Global Medical Imaging & Informatics Outlook, 2021

AI, Long-term Partnerships, and Cloud to Influence Growth Strategies

Infographics

×

The global medical imaging and informatics market is experiencing dynamic changes with the emergence of advanced technologies, evolving clinical and administrative needs, and the introduction of new policies and regulations, which is forcing industry participants to innovate to maintain their competitive edge. Technologies such as artificial intell...

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...

"Champions of health, unite" was the call to action of the annual Health Information and Management Systems Society (HIMSS) conference, held Feb. 11-15 in Orlando. The event, which attracted more than 43,000 attendees and 1,300 exhibitors, also featured more than 500 educational sessions plus daily keynote addresses and panel discussions featuring ...

This report provides a concise graphic snapshot of the changing face of the products and services which comprise the Customer Relationship Management market for U.S. pharmaceutical organizations from 2004-2007. It includes a breakdown of sub-markets, including SFA software, marketing/back office analytics software, and call center services. Each su...